NorthWest Biotherapeutics Inc (NWBO)

[SkyLimit2022]

https://www.wate.com/business/press-releases/ein-presswire/691968787/the-end-brain-cancer-initiative-ebci-advocates-for-dcvax-l-to-gain-fda-approval/



https://endbraincancer.org/wp-content/uploads/2024/02/DCVax-Press-Release.pdf

Our team just met with the @NorthwestBio team to learn about #DCVax and had the pleasure of speaking with longterm DCVax patients. An honor and a privilege. #endbraincancer #sno2023 pic.twitter.com/dw3X76DBru

— EndBrainCancer Initiative (@EndBrainCancer) November 19, 2023

The End Brain Cancer Initiative (EBCI) is advocating for FDA approval of DCVax-L®, a novel treatment for Glioblastoma (GBM) brain tumors, in anticipation of submittal of the application for FDA approval by Northwest Biotherapeutics. Read Press Release: https://t.co/XXK0z03dJV. pic.twitter.com/bBIk9LR33V

— EndBrainCancer Initiative (@EndBrainCancer) February 28, 2024

https://www.uclahealth.org/news/fda-approval-brain-cancer-Alzheimers

This study found that autologous tumor lystate-loaded dendritic cell vaccination plus standard of care (SOC) was associated with improved survival in both newly diagnosed & recurrent glioblastoma compared with matched controls who received SOC treatment. https://t.co/Uso7Pkh1Kt

— JAMA Oncology (@JAMAOnc) February 15, 2023

https://brownneurosurgery.com/breakthrough-brain-cancer-vaccine/

https://clinicaltrials.gov/study/NCT04201873